Uğur Şahin, the chief executive of BioNTech, says the vaccine his company developed with Pfizer should be effective against the new SARS-CoV-2 strain identified in the UK, the Guardian reports.
Uğur Şahin, the chief executive of BioNTech, says the vaccine his company developed with Pfizer should be effective against the new SARS-CoV-2 strain identified in the UK, the Guardian reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.